Education
About Us
Working with TipRanks
Follow Us
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
Earnings Data
Report Date
Mar 03, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.42Last Year’s EPS
-1.05Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
Phathom Pharmaceuticals had a strong Q3 with significant revenue growth and a substantial reduction in operating expenses and cash usage. The company is effectively executing its gastroenterology-focused strategy. However, there are potential challenges such as the temporary impact of sales force realignment and ongoing uncertainty in TRIPLE PAK supply.Company Guidance
Significant Revenue Growth
Phathom Pharmaceuticals reported a 25% revenue growth in Q3 2025, with net revenue reaching $49.5 million, which exceeded expectations and is in line with the revenue guidance for the year.
Reduction in Operating Expenses
Operating expenses were reduced by 43% quarter-over-quarter and nearly 50% since Q1 2025, contributing to a significant reduction in cash usage.
Cash Usage Down
Cash usage for Q3 was less than $15 million, a reduction of 77% compared to Q2 2025.
Strong Prescription Growth
There was a 36% growth in filled prescriptions since Q2, with 221,000 prescriptions in Q3, including 144,000 covered scripts and 77,000 cash prescriptions.
New Leadership Hires
The company welcomed Sanjeev Narula as the new Chief Financial and Business Officer and Nancy Phelan as the new SVP of Marketing and Analytics, both bringing significant experience to Phathom.
PHAT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
PHAT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 30, 2025 | $13.53 | $13.31 | -1.63% |
Aug 07, 2025 | $8.68 | $9.40 | +8.29% |
May 01, 2025 | $4.29 | $3.36 | -21.68% |
Mar 06, 2025 | $6.08 | $5.90 | -2.96% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Phathom Pharmaceuticals (PHAT) report earnings?
Phathom Pharmaceuticals (PHAT) is schdueled to report earning on Mar 03, 2026, Before Open (Confirmed).
What is Phathom Pharmaceuticals (PHAT) earnings time?
Phathom Pharmaceuticals (PHAT) earnings time is at Mar 03, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PHAT EPS forecast?
PHAT EPS forecast for the fiscal quarter 2025 (Q4) is -0.42.